Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas.
about
Reproducibility of academic preclinical translational research: lessons from the development of Hedgehog pathway inhibitors to treat cancerIdentification of critically carcinogenesis-related genes in basal cell carcinomaRole of GLI Transcription Factors in Pathogenesis and Their Potential as New Therapeutic TargetsHedgehog Signaling in Lung Cancer: From Oncogenesis to Cancer Treatment Resistance
P2860
Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Noncanonical hedgehog pathway ...... ance in basal cell carcinomas.
@en
Noncanonical hedgehog pathway ...... ance in basal cell carcinomas.
@nl
type
label
Noncanonical hedgehog pathway ...... ance in basal cell carcinomas.
@en
Noncanonical hedgehog pathway ...... ance in basal cell carcinomas.
@nl
prefLabel
Noncanonical hedgehog pathway ...... ance in basal cell carcinomas.
@en
Noncanonical hedgehog pathway ...... ance in basal cell carcinomas.
@nl
P2093
P2860
P50
P356
P1433
P1476
Noncanonical hedgehog pathway ...... ance in basal cell carcinomas.
@en
P2093
Alexander S Brown
Amar Mirza
Catherine Y Yao
Ervin H Epstein
Eunice Y Lee
Gautam Shankar
Jean Y Tang
Jiang R Li
Matthew P Scott
P2860
P2888
P304
P356
10.1038/NM.4476
P407
P577
2018-02-05T00:00:00Z